PIERALLI, FILIPPO
 Distribuzione geografica
Continente #
EU - Europa 390
NA - Nord America 323
AS - Asia 98
Totale 811
Nazione #
US - Stati Uniti d'America 322
IT - Italia 204
IE - Irlanda 52
SE - Svezia 46
HK - Hong Kong 41
RU - Federazione Russa 34
PL - Polonia 22
CN - Cina 16
SG - Singapore 16
JO - Giordania 14
CH - Svizzera 13
NL - Olanda 10
KR - Corea 5
GB - Regno Unito 3
DE - Germania 2
FI - Finlandia 2
IN - India 2
IR - Iran 2
UA - Ucraina 2
VN - Vietnam 2
MX - Messico 1
Totale 811
Città #
Dublin 52
Chandler 49
Ashburn 46
Fairfield 35
Hong Kong 29
Warsaw 22
Moscow 15
Woodbridge 15
Altamura 14
Lawrence 14
Houston 13
Singapore 13
Milan 12
Wilmington 12
Bern 11
Rome 11
Princeton 10
Amsterdam 9
Buffalo 9
Florence 9
Medford 9
Seattle 8
Bergamo 7
Cambridge 7
Los Angeles 7
New York 6
Shanghai 6
Ann Arbor 5
San Diego 5
San Jose 5
Seoul 5
Bologna 4
Napoli 4
Padova 4
Beijing 3
Boston 3
Grado 3
Kent 3
Lamezia Terme 3
Norwalk 3
Pomigliano d'Arco 3
Siena 3
Verona 3
Brescia 2
Camposampiero 2
Chengdu 2
Cologno al Serio 2
Dong Ket 2
Fucecchio 2
Genoa 2
Incisa 2
Lecco 2
Mountain View 2
Musile di Piave 2
Naples 2
Novara 2
Palermo 2
Pescara 2
Poggibonsi 2
San Casciano in Val di Pesa 2
San Giovanni Valdarno 2
Sant'elpidio A Mare 2
Stockton 2
Treviglio 2
Treviso 2
Trieste 2
Washington 2
Abenberg 1
Andover 1
Avellino 1
Boardman 1
Borgo San Lorenzo 1
Bremen 1
Caselle Lurani 1
Castelfidardo 1
Catania 1
Catanzaro 1
Cedar Knolls 1
Chicago 1
Chihuahua City 1
Como 1
Falconara Marittima 1
Fiesole 1
Follonica 1
Frattamaggiore 1
Gossolengo 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Hillsboro 1
Hounslow 1
Jacksonville 1
Karur 1
Kish 1
Lappeenranta 1
Leawood 1
Mariano Comense 1
Miami 1
Monteriggioni 1
Perugia 1
Totale 590
Nome #
Hot topics In Pneumologia Interventistica Vol. 3 225
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 99
Performance of the CHA 2 DS 2 -VASc score in predicting new onset atrial fibrillation during hospitalization for community-acquired pneumonia 65
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: Impact on patient outcome 58
The doctor who stared at schistocytes: an intriguing case of suspected thrombotic microangiopathic anemia 56
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection 49
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 46
The eighth alternative to evidence based medicine in the early era of the COVID-19 pandemic: Too much emergency and emotion, too little evidence 46
High-dose steroids for the treatment of severe COVID-19 40
Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real life study 37
Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: A multicenter prospective study 36
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy 21
Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022 21
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 17
Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study 14
When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report 6
Totale 836
Categoria #
all - tutte 4.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 5 4 4 6 4 2 0 3
2020/2021132 3 8 21 22 8 5 7 15 9 9 9 16
2021/202289 6 2 3 5 6 7 0 8 6 4 18 24
2022/2023271 21 52 15 8 10 49 33 18 26 9 14 16
2023/2024273 7 16 25 18 19 50 6 57 13 32 18 12
2024/202543 27 16 0 0 0 0 0 0 0 0 0 0
Totale 836